Medicare Enrolled
Munir Ahmad
Hematology & Oncology · Lufkin, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Ahmad from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Ahmad?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Ahmad
Munir Ahmad is a hematology & oncology specialist in Lufkin, TX, with 20 years of NPI registration. Based on federal Medicare data, Ahmad performed 47,821 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Ahmad received a total of $3,154 from 36 pharmaceutical and/or device companies across 102 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Ahmad is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 20% volume in TX
$3,154 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗47,821
Medicare services
Top 20% in TX for hematology & oncology
Not available
Unique patients (not deduplicated)
$7
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
23,970 | $0 | $3 |
| Denosumab injection (Prolia/Xgeva) | 5,340 | $18 | $55 |
| Epoetin alfa injection (Retacrit) for anemia An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units. |
4,820 | $6 | $45 |
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
4,500 | $0 | $2 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
2,301 | $0 | $1 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,420 | $0 | $5 |
| Anti-nausea injection (Aloxi/palonosetron) | 930 | $1 | $51 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
904 | $8 | $25 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
884 | $8 | $65 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
360 | $95 | $350 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
297 | $12 | $80 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
266 | $65 | $250 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
207 | $100 | $550 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
206 | $11 | $65 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
203 | $22 | $205 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
179 | $22 | $225 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
124 | $18 | $250 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
83 | $1 | $15 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
77 | $56 | $145 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
71 | $48 | $250 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
61 | $50 | $275 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
61 | $117 | $475 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
53 | $10 | $110 |
| Blood glucose test using reagent strip A test that measures the level of sugar in the blood using a chemical reagent strip. |
51 | $5 | $10 |
| Blood glucose test using hand-held instrument A test that measures the level of sugar in the blood using a portable device. The result helps monitor blood glucose levels. |
51 | $3 | $10 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
50 | $1,164 | $7,122 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
50 | $1 | $48 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 48 | $128 | $650 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
47 | $0 | $22 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
43 | $133 | $450 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
33 | $22 | $85 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
26 | $2 | $25 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
25 | $69 | $250 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
24 | $73 | $1,140 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
24 | $220 | $1,800 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
20 | $26 | $130 |
| CT scan of chest, without contrast A computed tomography scan of the chest area that uses X-rays to create detailed images without the use of contrast dye. |
12 | $101 | $900 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
51.4% high complexity
42.3% medium
6.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$3,154
Total received (2018-2024)
Avg $451/year across 7 years
Top 50% in TX for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
36
Companies
102
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$921
2023
$582
2022
$123
2021
$326
2020
$159
2019
$427
2018
$615
Payments by company (2024)
Novartis Pharmaceuticals Corporation
$167
Celgene Corporation
$119
Daiichi Sankyo Inc.
$110
ABBVIE INC.
$103
PFIZER INC.
$77
GlaxoSmithKline, LLC.
$61
JAZZ PHARMACEUTICALS INC.
$38
SUN PHARMACEUTICAL INDUSTRIES INC.
$31
AstraZeneca Pharmaceuticals LP
$27
Tempus AI, Inc
$27
Eisai Inc.
$26
Ipsen Biopharmaceuticals, Inc
$26
Deciphera Pharmaceuticals Inc.
$24
Incyte Corporation
$19
Kite Pharma, Inc.
$17
Stemline Therapeutics Inc.
$17
Bayer Healthcare Pharmaceuticals Inc.
$17
PUMA BIOTECHNOLOGY, INC.
$16
Top 3 companies account for 43.0% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$294
Genentech USA, Inc.
$224
Amgen Inc.
$223
Novartis Pharmaceuticals Corporation
$211
Seagen Inc.
$203
E.R. Squibb & Sons, L.L.C.
$199
Pharmacyclics LLC, An AbbVie Company
$195
Celgene Corporation
$119
GlaxoSmithKline, LLC.
$111
Daiichi Sankyo Inc.
$110
PFIZER INC.
$106
ABBVIE INC.
$103
Alexion Pharmaceuticals, Inc.
$99
Seattle Genetics, Inc.
$99
Kite Pharma, Inc.
$94
Takeda Pharmaceuticals U.S.A., Inc.
$92
Lilly USA, LLC
$86
Boehringer Ingelheim Pharmaceuticals, Inc.
$83
Janssen Scientific Affairs, LLC
$82
Ipsen Biopharmaceuticals, Inc
$54
Stemline Therapeutics Inc.
$47
JAZZ PHARMACEUTICALS INC.
$38
SUN PHARMACEUTICAL INDUSTRIES INC.
$31
Sun Pharmaceutical Industries Inc.
$29
Tempus AI, Inc
$27
Jazz Pharmaceuticals Inc.
$27
Eisai Inc.
$26
Deciphera Pharmaceuticals Inc.
$24
Genmab U.S., Inc.
$21
Incyte Corporation
$19
GENZYME CORPORATION
$17
Bayer Healthcare Pharmaceuticals Inc.
$17
PUMA BIOTECHNOLOGY, INC.
$16
Pharmacyclics LLC, an AbbVie Company
$15
Janssen Pharmaceuticals, Inc
$14
Janssen Biotech, Inc.
$1
Top 3 companies account for 23.5% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · BLENREP · BOSULIF · CYRAMZA · EMPLICITI · EPKINLY · Enhertu · Erleada · Fabhalta · GILOTRIF · IBRANCE · IMBRUVICA · IMFINZI · INLYTA · JAKAFI · JEMPERLI · KISQALI · Kyprolis · LUTATHERA · Lenvima · OJJAARA · OPDIVO · Odomzo · Onivyde · Orserdu · PADCEV · PIQRAY · PROMACTA · Pomalyst · QINLOCK · SARCLISA · SCEMBLIX · SOLIRIS · Stivarga · TAGRISSO · TECENTRIQ · Tivdak · VELCADE · VENCLEXTA · XARELTO · XT CDX · YONSA · Yescarta · ZEPZELCA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
3
County median income
$58,847
Nearest hospital to ZIP centroid (approximate)
WOODLAND HEIGHTS MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Ahmad is a mixed practice specialist, with above-average Medicare volume (top 20% in TX), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Ahmad experienced with iron infusion (feraheme)?
Based on Medicare claims data, Ahmad performed 23,970 iron infusion (feraheme) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Ahmad receive payments from pharmaceutical companies?
Yes. Ahmad received a total of $3,154 from 36 companies across 102 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Ahmad's costs compare to other hematology & oncology specialists in Lufkin?
Ahmad's average Medicare payment per service is $7. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Ahmad) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Lufkin
Browse hematology & oncology specialists in Lufkin ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in TX
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in TX
Which TX hematology & oncology specialists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology